Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Selvi Durmus Rolf W Sparidans Alfred H Schinkel Jos Beijnen |
| Publication date | October 18, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |